Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Efficacy of Opti-Speech, a 3D Visual Feedback System, for Speech Treatment

NCT02705326 is registered in ClinicalTrials.gov with Vulintus, Inc. as lead sponsor.

NCT NCT02705326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02705326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Efficacy of Opti-Speech, a 3D Visual Feedback System, for Speech Treatment
Lead sponsor
Vulintus, Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2016
Completion date
August 31, 2018
Enrollment
37 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

articulation disorder, dysarthria, prelingual deafness